Zacks Small Cap Research – CCLD: 1Q25 Earnings Review – Slight EPS Miss on Higher Expenses; Multi-Layered Growth Story – Go Health Pro

By Michael Kim NASDAQ:CCLD READ THE FULL CCLD RESEARCH REPORT Pre-market open on 5/6/25, CareCloud (NASDAQ:CCLD) reported 1Q25 earnings results. For the quarter, CCLD reported GAAP net income of $1.9 million – the company’s fourth consecutive positive net income quarter, and a reversal from a net loss of $0.2 million for the year-ago quarter. After … Read more

Zacks Small Cap Research – SDA: SunCar Technology’s Strong Growth Potential Supports Price Target of $13.00 – Go Health Pro

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT 2024 Financial and Operating Results On April 28, 2025, SunCar (NASDAQ:SDA) released full year 2024 results which showed impressive revenue and EBITDA growth. Total company revenues increased 21% to $441.9 million for the full year 2024. This compares to $363.7 million in 2023. Auto … Read more

Zacks Small Cap Research – HIT: Newly Formed Advisory Board and Advisor With Extensive Public Affairs Experience Appear Timely – Go Health Pro

By M. Marin NASDAQ:HIT READ THE FULL HIT RESEARCH REPORT New Board member: extensive experience in public affairs & policy… Health in Tech (NASDAQ:HIT) is an insurtech operating an AI-powered online marketplace platform to facilitate and improve employers’ ability to obtain health insurance. The company, which provides enterprise SaaS (Software-as-a-Service) solutions for online processing and … Read more

Zacks Small Cap Research – GMGI: Balance Sheet Strengthened, Financial Flexibility Enhanced, With Debt Reduction – Go Health Pro

Zacks Small Cap Research – GMGI: Balance Sheet Strengthened, Financial Flexibility Enhanced, With Debt Reduction – Go Health Pro

By M. Marin NASDAQ:GMGI READ THE FULL GMGI RESEARCH REPORT Balance sheet strengthened with debt reduction Golden Matrix Group (NASDAQ:GMGI), an iGaming group providing a broad array of gaming products and software solutions on a B2B and B2C basis, strengthened its balance sheet by paying down debt. The company had issued Lind Global Asset Management … Read more

Zacks Small Cap Research – EVAX Provided Great Cancer Vaccine Update – Go Health Pro

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more